The Sherpa Suction Guide
VAP is the most expensive and most deadly hospital-acquired infection (HAI) leading to 6 extra days in the ICU, a 10% associated mortality, and $40k in treatment costs. Aspiration is widely recognized as the primary etiology of VAP but current subglottic suction ETTs are expensive and require broad, non-selective upfront use.
The Sherpa Suction Guide enables above-the-cuff placement of a suction catheter allowing for removal of high-risk pooled secretions. It is the first device of its kind to reliably reduce aspiration and the subsequent risk of VAP cost effectively. Compared to the current premium endotracheal tubes with embedded suctioning, our suction guide can save a single hospital over $100,000 per year by allowing for selective use in only the patients that need it.
The NEMO Gauge
Location of the endotracheal tube in a ventilated patient's airway is critical to ensure appropriate oxygen delivery. Today, millions of portable chest xrays are taken in the ICU to confirm tube location leading to workflow inefficiencies, radiation exposure and ICU cost.
Our solution is the NEMO Gauge - a simple, disposable catheter that can be used to measure endotracheal tube position in a matter of minutes. This commercially available device replaces x-rays with a 5 minute process performed by one person for less than 50% of the cost of a portable chest x-ray.
Kate Garrett, Co-Founder & CEO
Kate is the co-founder and CEO of Ciel Medical. Prior to Ciel Medical Kate worked in strategic marketing at Acclarent, and in R&D at Pathway Medical Technologies. She has been directly involved in the development and commercial launch of six 510(k) products. Kate has a mechanical engineering degree from Olin College and graduated from the Stanford Biodesign Fellowship for medtech innovation.
Dan Azagury, MD, Co-Founder & Board Member
Dan is the co-founder of Ciel Medical and an Assistant Professor of Surgery at Stanford University specializing in bariatric and minimally invasive surgery. Dan is on faculty at multiple medical innovation courses around the globe including Stanford Biodesign, Strausburg IHU BEST and Barcelona d.Health. He completed his medical training at Geneva University Hospital, surgery fellowships at Brigham & Women’s Hospital and the Biodesign Fellowship at Stanford University.
Jay Watkins, Board Member
Jay Watkins is a Managing Director at Curation Capital. Jay is an operating executive with extensive experience founding and funding healthcare companies including executive management roles at DeNovo Ventures, Guidant Corp and Origin MedSystems. He has served as a board member for both private and public medtech companies and has been an active advisor and faculty member for the Kauffman Labs program which is dedicated to educating and training founders. Jay received his MBA from Harvard Business School and his undergraduate degree from Stanford University.
Beverly Huss, Board Member
Beverly Huss is the President and CEO of Qool Therapeutics. Previously, she was President and CEO of Vibrynt, Inc. and a senior executive at Guidant Corp. Beverly serves on the board of Ulthera, Ciel Medical and the University of Illinois Material Science and Engineering steering committee and previously served on the boards of Dade Behring, Inc., Wright Medical Inc., and Artes Medical. She was the recipient of the 2013 University Of Illinois College Of Engineering Alumni Award for distinguished leadership in the medical device industry. Beverly holds a M.S. in technology management from Pepperdine University and a B.S. in metallurgical engineering from the University of Illinois.
Steve Ruoss, MD, Advisor
Steve Ruoss is the Clinical Chief, Division of Pulmonary and Critical Care Medicine at Stanford University School of Medicine. Steve is an entrepreneur and advisor to early stage medical device start-ups.
Alex Tilson, Advisor
Alex Tilson was the founder and CEO of Loma Vista Medical (acquired by CR Bard), a lean start-up that created highly innovative flexible composite medical balloons. Alex has over twenty years experience leading medical device teams. He is a Stanford mechanical engineer and earned an MBA from Harvard.
Karen Drexler, Advisor
Karen is a Managing Director of ExxClaim Capital. She co-founded multiple diagnostics companies, serves as Executive Chairman of CellScape and is a member of the board of directors of diaDexus. Karen provides CEO mentoring and supports women entrepreneurs through her work with Astia and Springboard Enterprises.